All Stories

  1. The Impact of Job Strain on Occupational Access to Firearms and Firearm‐Related Suicide Among US Workers
  2. Proximity to Healthcare Services Among Individuals With Duchenne Muscular Dystrophy
  3. Trends in Corticosteroid Use Among Males With Duchenne Muscular Dystrophy (DMD) During 2000-2015: Data From the MD STAR net
  4. Nationwide Danish Register Based Study Showed a Stable Prevalence of Congenital Diaphragmatic Hernias From 1994 to 2021 but a Decrease in Syndromic Cases
  5. Pain Experiences and Prescription Pain Medications Among People With Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
  6. Maternal Age Differences in Interpregnancy Interval and Preterm Birth Associations Accounting for Multiple Epidemiologic Biases
  7. Incidence trends and risk factors for Perthes’ disease in children born between 1985 and 2016
  8. Prophylactic Use of Cardiac Medications and Survival in Duchenne Muscular Dystrophy
  9. Respiratory function and evaluation in individuals with facioscapulohumeral muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network
  10. Associations Between Maternal Periconceptional Alcohol Consumption and Risk of Craniosynostosis Among Offspring, National Birth Defects Prevention Study, 1997–2011
  11. Omphalocele prevalence and co-occurring malformations: a nationwide register-based study of Danish live births in 1997–2021
  12. Gastroschisis prevalence and co-occurring malformations among Danish live births during 1994-2021: A nationwide register-based study
  13. Survival of Children With Critical Congenital Heart Defects in the National Birth Defects Prevention Study
  14. Maternal Exposure to Tap Water Disinfection By‐Products and Risk of Selected Congenital Heart Defects
  15. Multiple Job Holding, Job Changes, and Associations with Gestational Diabetes and Pregnancy-Related Hypertension in the National Birth Defects Prevention Study
  16. Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997–2011
  17. Bias analyses to investigate the impact of differential participation: Application to a birth defects case‐control study
  18. Prophylactic use of cardiac medications for delay of left ventricular dysfunction in Duchenne muscular dystrophy
  19. Trends in congenital clubfoot prevalence and co-occurring anomalies during 1994–2021 in Denmark: a nationwide register-based study
  20. Using a health observance event to raise awareness: An assessment of World Birth Defects Day
  21. Trends in congenital clubfoot prevalence and co-occurring anomalies during 1994-2021 in Denmark: A nationwide register-based study of 1,315,282 live born infants
  22. Maternal dietary caffeine consumption and risk of birth defects in the National Birth Defects Prevention Study , 1997–2011
  23. Assessing associations between residential proximity to greenspace and birth defects in the National Birth Defects Prevention Study
  24. TBX3 and EFNA4 Variant in a Family with Ulnar-Mammary Syndrome and Sagittal Craniosynostosis
  25. Pregnancy and infant outcomes by trimester of SARS‐CoV ‐2 infection in pregnancy– SET‐NET , 22 jurisdictions, January 25, 2020–December 31, 2020
  26. Targeted Sequencing of Candidate Regions Associated with Sagittal and Metopic Nonsyndromic Craniosynostosis
  27. Time to Diagnosis of Duchenne Muscular Dystrophy Remains Unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network ( MD STAR net ), 2...
  28. Patterns of multiple congenital anomalies in the National Birth Defect Prevention Study: Challenges and insights
  29. Factors associated with maternal consent for use of residual newborn bloodspots in the National Birth Defects Prevention Study
  30. Direct costs of adhering to selected Duchenne muscular dystrophy care considerations: estimates from a Midwestern state
  31. Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study
  32. Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
  33. Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor
  34. Association between maternal periconceptional alcohol consumption and neural tube defects: Findings from the National Birth Defects Prevention Study, 1997–2011
  35. Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy
  36. Pre‐pregnancy dietary arsenic consumption among women in the United States
  37. Population‐based birth defects data in the United States, 2012–2016: A focus on abdominal wall defects
  38. Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015
  39. Quantifying geographic regions of excess stillbirth risk in the presence of spatial and spatio-temporal heterogeneity
  40. Needs management in families affected by childhood-onset dystrophinopathies
  41. Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population‐based retrospective study, 1999–2010
  42. Maternal arsenic exposure and nonsyndromic orofacial clefts
  43. A Review of MD STARnet’s Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017
  44. A population-based case-control study of the association between weather-related extreme heat events and orofacial clefts
  45. Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study
  46. Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011
  47. Maternal occupational cadmium exposure and nonsyndromic orofacial clefts
  48. Copy number variants in Ebstein anomaly
  49. Clinical and risk factor analysis of cloacal defects in the National Birth Defects Prevention Study
  50. Population-based case-control study of the association between weather-related extreme heat events and neural tube defects
  51. Copy-number variants and candidate gene mutations in isolated split hand/foot malformation
  52. Application of the International Classification of Functioning, Disability and Health system to symptoms of the Duchenne and Becker muscular dystrophies
  53. Factors associated with employment status before and during pregnancy: Implications for studies of pregnancy outcomes
  54. Identifying birth defects in automated data sources in the Vaccine Safety Datalink
  55. Genetic Variants in Isolated Ebstein Anomaly Implicated in Myocardial Development Pathways
  56. Maternal periconceptional alcohol consumption and congenital heart defects
  57. Genitourinary health in a population-based cohort of males with Duchenne and Becker Muscular dystrophies
  58. Stillbirth surveillance consortium
  59. Neurobehavioral Concerns Among Males with Dystrophinopathy Using Population-Based Surveillance Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network
  60. Indirect and Direct Perceived Behavioral Control and the Role of Intention in the Context of Birth Control Behavior
  61. Novel copy-number variants in a population-based investigation of classic heterotaxy
  62. Maternal periconceptional alcohol consumption and congenital limb deficiencies
  63. Maternal periconceptional occupational pesticide exposure and neural tube defects
  64. Assessing bottled water nitrate concentrations to evaluate total drinking water nitrate exposure and risk of birth defects
  65. Complementary and Alternative Medicine for Duchenne and Becker Muscular Dystrophies: Characteristics of Users and Caregivers
  66. Examination of Mental Health Status and Aggravation Level Among Mothers of Children With Isolated Oral Clefts
  67. Exploring Maternal Patterns of Dietary Caffeine Consumption Before Conception and During Pregnancy
  68. Descriptive and risk factor analysis for choanal atresia: The National Birth Defects Prevention Study, 1997–2007
  69. Maternal periconceptional occupational exposure to pesticides and selected musculoskeletal birth defects
  70. Maternal Hypertension, Medication Use, and Hypospadias in the National Birth Defects Prevention Study
  71. Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings
  72. Maternal Caffeine Consumption and Small for Gestational Age Births: Results from a Population-Based Case–Control Study
  73. Self-Reported Maternal Cigarette Smoke Exposure during the Periconceptional Period and the Risk for Omphalocoele
  74. Factors affecting maternal participation in the genetic component of the National Birth Defects Prevention Study—United States, 1997–2007
  75. Plasma Lipids, Genetic Variants Near APOA1 , and the Risk of Infantile Hypertrophic Pyloric Stenosis
  76. Maternal Periconceptional Exposure to Cigarette Smoking and Congenital Limb Deficiencies
  77. Cancer Risk in Children and Adolescents with Birth Defects: A Population-Based Cohort Study
  78. Maternal Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Risk of Oral Cleft-Affected Pregnancies
  79. The association of low socioeconomic status and the risk of having a child with Down syndrome: a report from the National Down Syndrome Project
  80. Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control study
  81. Periconceptional maternal alcohol consumption and neural tube defects
  82. Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: A report from the National Down Syndrome Project
  83. Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy
  84. Anorectal atresia and Variants at Predicted Regulatory Sites in Candidate Genes
  85. Evaluation of genes involved in limb development, angiogenesis, and coagulation as risk factors for congenital limb deficiencies
  86. O-090
  87. Maternal caffeine consumption and risk of congenital limb deficiencies
  88. Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations
  89. Analysis of selected maternal exposures and non-syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005.
  90. Effect of survey instrument on participation in a follow-up study: a randomization study of a mailed questionnaire versus a computer-assisted telephone interview
  91. Maternal occupational exposure to polycyclic aromatic hydrocarbons and risk of neural tube defect‐affected pregnancies
  92. Hirschsprung’s disease and variants in genes that regulate enteric neural crest cell proliferation, migration and differentiation
  93. Nonsteroidal antiinflammatory drug use among women and the risk of birth defects
  94. Maternal Occupational Exposure to Polycyclic Aromatic Hydrocarbons: Effects on Gastroschisis among Offspring in the National Birth Defects Prevention Study
  95. Folate and vitamin B12-related genes and risk for omphalocele
  96. Use of active surveillance methodologies to examine over-reporting of stillbirths on fetal death certificates
  97. Maternal occupational pesticide exposure and risk of hypospadias in the national birth defects prevention study
  98. Associations between periconceptional alcohol consumption and craniosynostosis, omphalocele, and gastroschisis
  99. Maternal caffeine intake and risk of selected birth defects in the national birth defects prevention study
  100. Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects
  101. Maternal smoking, passive tobacco smoke, and neural tube defects
  102. Primary care physician experience with children with oral clefts in three states
  103. Maternal periconceptional exposure to cigarette smoking and alcohol consumption and congenital diaphragmatic hernia
  104. Prenatal Diagnosis of Orofacial Clefts: Association With Maternal Satisfaction, Team Care, and Treatment Outcomes
  105. Identification of Iowa Live Births in the Agricultural Health Study
  106. Epidemiology of congenital idiopathic talipes equinovarus in Iowa, 1997-2005
  107. Caffeine, selected metabolic gene variants, and risk for neural tube defects
  108. Patterns of tobacco exposure before and during pregnancy
  109. Maternal characteristics associated with the dietary intake of nitrates, nitrites, and nitrosamines in women of child-bearing age: a cross-sectional study
  110. Interdisciplinary Craniofacial Teams Compared With Individual Providers: Is Orofacial Cleft Care More Comprehensive and Do Parents Perceive Better Outcomes?
  111. Maternal caffeine consumption and risk of neural tube defects
  112. Demographic Characteristics, Care, and Outcomes for Children With Oral Clefts in Three States Using Participants From the National Birth Defects Prevention Study
  113. Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
  114. Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study
  115. Demographic Characteristics, Care and Outcomes for Children with Oral Clefts in Three States Using Participants from the National Birth Defects Prevention Study
  116. Maternal Reports of Satisfaction with Care and Outcomes for Children with Microtia
  117. Pesticides and hypospadias: A meta-analysis
  118. Bayesian Methods for Correcting Misclassification
  119. Maternal Reports of Satisfaction With Care and Outcomes for Children With Craniosynostosis
  120. Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects
  121. Maternal periconceptional exposure to cigarette smoking and alcohol and esophageal atresia ± tracheo-esophageal fistula
  122. Maternal Smoking and Congenital Heart Defects
  123. Alcohol Consumption by Women Before and During Pregnancy
  124. Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project
  125. Antifungal drugs and the risk of selected birth defects
  126. Maternal reports of family history from the National Birth Defects Prevention Study, 1997–2001
  127. Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias
  128. Meta-Analysis: Pesticides and Orofacial Clefts
  129. Maternal caffeine consumption and risk of cardiovascular malformations
  130. Maternal Smoking and Environmental Tobacco Smoke Exposure and the Risk of Orofacial Clefts
  131. Periconceptional consumption of vitamins containing folic acid and risk for multiple congenital anomalies
  132. Orofacial Cleft Risk Is Increased with Maternal Smoking and Specific Detoxification-Gene Variants
  133. Ultrasound findings in 34 cases of trisomy 13
  134. Type of Oral Cleft and Mothers' Perceptions of Care, Health Status, and Outcomes for Preadolescent Children
  135. PVRL1 variants contribute to non-syndromic cleft lip and palate in multiple populations
  136. The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): Surveillance methodology
  137. In vitro fertilization is associated with an increase in major birth defects
  138. The use of pesticides in a Polish rural population and its effect on birth weight
  139. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genesMTHFR,MTHFD,MTRR,RFC1, andGCP2
  140. Complex segregation analysis of 1,792 cleft lip and palate families in South America: 1967-1997
  141. Integration of DNA sample collection into a multi-site birth defects case-control study
  142. Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2): Structure, gene mapping, polymorphisms, and candidate evaluation for human orofacial clefts
  143. Acceptability of Telepsychiatry to a Rural Population
  144. Evaluation of reports of periconceptual occupational exposure: Maternal‐assessed versus industrial hygienist‐assessed exposure
  145. Evaluation of reports of periconceptual occupational exposure: Maternal-assessed versus industrial hygienist-assessed exposure
  146. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: Evaluation of genotype-environment interactions from a population-based case-control study of orofacial clefts
  147. Association of MSX1 and TGFB3 with Nonsyndromic Clefting in Humans
  148. Maternal interview reports of family history of birth defects: Evaluation from a population-based case-control study of orofacial clefts
  149. Feasibility of Collecting Disease Reports from Relatives for Genetic Epidemiologic Investigations
  150. Maternal alcohol use and risk of orofacial cleft birth defects